![]() | |
Clinical data | |
---|---|
Trade names | Senvelgo |
License data | |
Routes of administration | By mouth |
ATCvet code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C23H25NO5 |
Molar mass | 395.455 g·mol−1 |
3D model (JSmol) | |
| |
|
Velagliflozin, sold under the brand nameSenvelgo, is anantidiabetic medication used for the treatment of cats.[2][4][5] Velagliflozin is asodium-glucose cotransporter 2 (SGLT2) inhibitor.[6] It is takenby mouth.[2]
Velagliflozin isindicated to improve glycemic control in otherwise healthy cats with diabetes not previously treated with insulin.[2][4][6]
![]() | Thisveterinary medicine–related article is astub. You can help Wikipedia byexpanding it. |